The primary purpose of this study is to help answer the following research questions:~Whether this drug can help symptoms of aggression and agitation in participants with Alzheimer's Disease.~The safety of this drug and any side effects that might be associated with it.~How this drug compares to placebo.~During the 12-week period of this study, the participant will have an equal chance of receiving 1 of the 2 treatment groups: active drug or placebo.
The purpose of this study is to determine whether this drug can help symptoms of aggression and agitation in participants with Alzheimer's disease.